Related Experiment Video
Updated: May 5, 2026
12:35
In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
Published on: November 10, 2011
20.3K
Circulating immune complexes in patients with fulminant hepatic failure
Gut
|October 1, 1981
Summary
Circulating immune complexes are common in fulminant hepatic failure from viral hepatitis and halothane anesthesia but less so in paracetamol-induced liver injury. These complexes may indicate immune-mediated liver damage.
Area of Science:
- Hepatology
- Immunology
- Toxicology
Background:
- Fulminant hepatic failure (FHF) is a severe clinical syndrome with high mortality.
- The role of circulating immune complexes (CICs) in the pathogenesis of FHF remains unclear.
- Previous studies suggest a potential link between CICs and liver injury, but data across different etiologies are limited.
Purpose of the Study:
- To investigate the prevalence and significance of CICs in patients with FHF of varying etiologies.
- To determine if CIC levels correlate with disease severity, renal function, or outcome.
- To explore the relationship between CICs, reticuloendothelial system (RES) function, and immune-mediated liver injury.
Main Methods:
- Measurement of CICs in patients with FHF due to viral hepatitis, halothane anesthesia, and paracetamol overdose.
- Assessment of RES function using the clearance of 125I microaggregated albumin.
- Correlation analysis of CIC levels with clinical parameters, including disease severity, renal failure, hypocomplementaemia, and patient outcomes.
Main Results:
- CICs were detected in a high proportion of patients with viral hepatitis-induced FHF (15/16) and halothane-associated FHF (6/6).
- A lower prevalence of CICs was observed in paracetamol-induced hepatic necrosis (5/32).
- CIC levels did not correlate with clinical course severity, renal failure, hypocomplementaemia, or patient outcome.
- All patients exhibited impaired RES function, irrespective of CIC levels or FHF etiology.
Conclusions:
- The presence of CICs in FHF is not solely a consequence of liver necrosis or RES dysfunction.
- CICs in FHF appear to reflect an immune response potentially contributing to immune-mediated liver injury.
- Further research is warranted to elucidate the precise mechanisms by which CICs mediate liver damage in FHF.
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
01:29Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
01:19Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269